Cite
A TGF‐β signaling‐related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response.
MLA
Duan, Wei‐Wei, et al. “A TGF‐β Signaling‐related LncRNA Signature for Prediction of Glioma Prognosis, Immune Microenvironment, and Immunotherapy Response.” CNS Neuroscience & Therapeutics, vol. 30, no. 4, Apr. 2024, pp. 1–18. EBSCOhost, https://doi.org/10.1111/cns.14489.
APA
Duan, W., Yang, L., Liu, J., Dai, Z., Wang, Z., Zhang, H., Zhang, X., Liang, X., Luo, P., Zhang, J., Liu, Z., Zhang, N., Mo, H., Qu, C., Xia, Z., & Cheng, Q. (2024). A TGF‐β signaling‐related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response. CNS Neuroscience & Therapeutics, 30(4), 1–18. https://doi.org/10.1111/cns.14489
Chicago
Duan, Wei‐Wei, Li‐Ting Yang, Jian Liu, Zi‐Yu Dai, Ze‐Yu Wang, Hao Zhang, Xun Zhang, et al. 2024. “A TGF‐β Signaling‐related LncRNA Signature for Prediction of Glioma Prognosis, Immune Microenvironment, and Immunotherapy Response.” CNS Neuroscience & Therapeutics 30 (4): 1–18. doi:10.1111/cns.14489.